CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC. – Trademark Portfolio

Entity Type: 03

CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include E-Z-GRAPH. The owner is based in WACO, TX.

P.O. BOX 8160

WACO, TX 76702

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

E-Z-GRAPH
E-Z-GRAPH
Registered 1997

Trademark Classifications

CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC. have?

CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC. file in?

CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC.'s most well-known trademarks?

CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC.'s registered trademark portfolio includes well-known marks such as E-Z-GRAPH. These are among 1 currently registered trademark in the portfolio.

What is CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC.'s trademark registration success rate?

CARDIO-PULMONARY THERAPEUTICS & DIAGNOSTICS, INC. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.